IE36780B1 - New pharmaceutical preparations - Google Patents

New pharmaceutical preparations

Info

Publication number
IE36780B1
IE36780B1 IE1403/72A IE140372A IE36780B1 IE 36780 B1 IE36780 B1 IE 36780B1 IE 1403/72 A IE1403/72 A IE 1403/72A IE 140372 A IE140372 A IE 140372A IE 36780 B1 IE36780 B1 IE 36780B1
Authority
IE
Ireland
Prior art keywords
pharmaceutical preparations
new pharmaceutical
preparations
us3883656a
hypertonia
Prior art date
Application number
IE1403/72A
Other languages
English (en)
Other versions
IE36780L (en
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of IE36780L publication Critical patent/IE36780L/xx
Publication of IE36780B1 publication Critical patent/IE36780B1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IE1403/72A 1971-11-11 1972-10-17 New pharmaceutical preparations IE36780B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH1637771 1971-11-11
CH1354572 1972-09-15

Publications (2)

Publication Number Publication Date
IE36780L IE36780L (en) 1973-05-11
IE36780B1 true IE36780B1 (en) 1977-02-16

Family

ID=25712489

Family Applications (1)

Application Number Title Priority Date Filing Date
IE1403/72A IE36780B1 (en) 1971-11-11 1972-10-17 New pharmaceutical preparations

Country Status (9)

Country Link
US (1) US3883656A (fr)
AU (1) AU4864272A (fr)
BE (1) BE791253A (fr)
DE (1) DE2254018A1 (fr)
FR (1) FR2159413B1 (fr)
GB (1) GB1405949A (fr)
IE (1) IE36780B1 (fr)
IL (1) IL40597A (fr)
NL (1) NL7214607A (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4389415A (en) * 1978-01-24 1983-06-21 Merck & Co., Inc. Method of treating hypertension
US4321264A (en) * 1980-04-14 1982-03-23 Merck & Co., Inc. α-methyldopa compositions
EP0374764B1 (fr) * 1988-12-19 2001-04-04 Nec Corporation Appareil de transmission de données

Also Published As

Publication number Publication date
FR2159413A1 (fr) 1973-06-22
IL40597A0 (en) 1972-12-29
GB1405949A (en) 1975-09-10
IL40597A (en) 1976-06-30
US3883656A (en) 1975-05-13
DE2254018A1 (de) 1973-05-30
NL7214607A (fr) 1973-05-15
FR2159413B1 (fr) 1975-08-08
BE791253A (fr) 1973-05-10
IE36780L (en) 1973-05-11
AU472689B2 (fr) 1976-06-03
AU4864272A (en) 1974-05-09

Similar Documents

Publication Publication Date Title
PH12097A (en) Pharmaceutically active pepiide and composition thereof
CA930668A (en) Bandage for administering drugs
IE36780B1 (en) New pharmaceutical preparations
ATA401872A (de) Bildmischschaltung
CA961041A (en) 1-methyl-3-alkoxymethyl-5,5-disub-stituted barbituric acid compounds and therapeutic compositions containing same
ZA714785B (en) A pharmaceutical composition containing a pharmaceutically active compound
CA985630A (en) Pharmaceutical composition having analgesic and antiphlogistic activities
GB1375806A (fr)
AU1615570A (en) Newk-alkyl-6-azauracil compounds and preparations which contain a 1-alkyl-6-azauracil compounds asan active ingredient
GB1299037A (en) Dithiocarbamic acid esters
GB1246727A (en) Therapeutic hypotensive compositions comprising 5-alkylpicolinic acids
AU426565B2 (en) Bandage for administering drugs
GB1287433A (en) Pharmaceutical compositions
IL38864A (en) Pharmaceutical compositions containing a pharmaceutically active penicillin and a penicilloic acid derivative
CA969477A (en) Pharmaceutical preparation containing analgetic compounds and psychopharmacologically active compounds
CA945544A (en) 16-METHYLENE-9.beta., 10.alpha.-STEROID COMPOUNDS, PHARMACEUTICAL PREPARATIONS WHICH CONTAIN THE NOVEL COMPOUNDS AS ACTIVE INGREDIENTS, AND METHODS OF PRODUCING THE SAID COMPOUNDSAND PREPARATIONS
AU281945B2 (en) Therapeutic composition containing dimethylamino-3, 5, 6-trimethyl-pyrazine or its salts and process for preparation ofthe active ingredient
GB1345319A (en) Pharmaceutically active thioalkylamine
CA981579A (en) Pharmaceutical composition comprising a derivative of 2-p-chlorophenoxy-2-methylpropionic acid and vitamin e
CA801708A (en) Therapeutic compositions of styrylpyridinium compounds and method of administering the same
CA1009242A (en) Metabolism-regulating composition and process for the preparation of the active ingredient
AU5019364A (en) Therapeutic composition containing dimethylamino-3, 5, 6-trimethyl-pyrazine or its salts and process for preparation ofthe active ingredient
IL46346A (en) Pharmaceutical compositions having synergistic analgesic activity comprising a 14-hydroxyazidomorphine derivative and a 1,6-dialkyl-4-oxohompyrimidazole-3-carboxylic acid derivative
GB1256735A (fr)
AU226290B2 (en) Composition containing an aminobenzodioxane or pharmaceutically acceptable salts thereof as active ingredient adapted for therapeutic administration